Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Spatial arrangement of inhibitory connections shapes brain network criticality

13

Nov 2026

Spatial arrangement of inhibitory connections shapes brain network criticality

In neuroscience, the brain criticality hypothesis proposes that neurons in the brain are arranged in such a way that neural activity lies at or near a transition point between two extremes: an ordered state where neural activity dies out quickly and a disordered state where neural activity tends to spread quickly and potentially grow uncontrollably.

Weill Cornell Medicine receives grant to track elder mistreatment

13

Nov 2026

Weill Cornell Medicine receives grant to track elder mistreatment

Weill Cornell Medicine has received a two-year, $1.4 million grant from the National Institute on Aging (NIA) to develop a national data infrastructure that will support efforts to better understand the health consequences of elder mistreatment and guide approaches to protect vulnerable older adults.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.